MAIA Biotechnology (MAIA) News Today → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free MAIA Stock Alerts $3.28 +0.13 (+4.13%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placementbusinesswire.com - April 30 at 8:08 AMMAIA Biotechnology Shares Hit 52-Week High After Director Stock Purchasemarketwatch.com - April 29 at 1:10 PMMAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placementbusinesswire.com - April 29 at 8:08 AMMAIA Biotechnology, Inc. (MAIA)finance.yahoo.com - April 28 at 12:48 PMNgar Yee Louie Acquires 19,665 Shares of MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Stockamericanbankingnews.com - April 28 at 5:30 AMMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Ngar Yee Louie Acquires 19,665 Sharesinsidertrades.com - April 27 at 7:15 AMMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Acquires $39,919.95 in Stockmarketbeat.com - April 26 at 8:04 PMMAIA Biotechnology Announces $1.00 Million Private Placementbusinesswire.com - April 23 at 8:51 AMMAIA Biotechnology to Present at Two Investor Conferences in April 2024businesswire.com - April 5 at 8:01 AMeFFECTOR shelves tomivosertib in NSCLC following Phase II failuremsn.com - April 4 at 11:05 PMMAIA Biotechnology directors buy shares amid development pushinvesting.com - March 28 at 7:38 PMMAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrerobusinesswire.com - March 28 at 3:00 PMMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placementbusinesswire.com - March 26 at 3:00 PMMAIA Biotechnology Announces $1.33 Million Private Placementbusinesswire.com - March 26 at 8:01 AMMAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placementbusinesswire.com - March 22 at 3:00 PMMAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Boardbusinesswire.com - March 21 at 3:00 PMMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Buys $199,999.80 in Stockinsidertrades.com - March 16 at 9:43 AMDirector Ngar Louie Acquires 170,940 Shares of MAIA Biotechnology Inc (MAIA)finance.yahoo.com - March 16 at 9:36 AMMAIA Biotechnology rises 3% on $2.92M private placementmsn.com - March 14 at 10:43 AMMAIA Biotechnology to Participate in the 36th Annual ROTH Conferencefinance.yahoo.com - March 7 at 1:49 PMMAIA Biotechnology nears end of Phase 2 cancer trialinvesting.com - March 7 at 12:55 AMMAIA Announces Positive Data From Phase 2 THIO Clinical Trial For NSCLC; Stock Rises 8%markets.businessinsider.com - March 6 at 7:55 PMMAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meetingfinance.yahoo.com - March 6 at 7:55 PMMAIA Biotechnology and Nationwide Children's Hospital Announce Presentation of THIO's Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meetingbusinesswire.com - March 6 at 11:04 AMMAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patientsbusinesswire.com - March 6 at 8:48 AMMAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholdersfinance.yahoo.com - March 5 at 9:37 AMMAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisorglobenewswire.com - February 27 at 10:30 AMMAIA Biotechnology concludes subject enrolment in NSCLC therapy trialmsn.com - February 23 at 1:28 PMMAIA Biotechnology, Inc.: MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancerfinanznachrichten.de - February 22 at 4:04 PMMAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancerglobenewswire.com - February 22 at 10:30 AMLatest News for MAIA Biotechnology Stock (AMEX:MAIA)benzinga.com - February 8 at 8:04 AMMAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancerstockhouse.com - February 7 at 11:05 AMNovel Therapy Shows Promising Results In On-Going Trials, Receives 3 Orphan Drug Designations From The FDAbenzinga.com - February 6 at 1:24 PMMAIA Biotechnology Patent Boosts Cancer Treatment Potentialmsn.com - January 31 at 7:44 AMMAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting Compoundsfinance.yahoo.com - January 24 at 9:00 AMMAIA Soars 20% on Interim Results From Lung Cancer Studymsn.com - January 18 at 3:03 PMMNTS, VVPR and BETS among pre-market losersmsn.com - January 12 at 8:55 AMMAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024finance.yahoo.com - January 5 at 12:18 PMOnconetix Incmoney.usnews.com - December 26 at 3:30 PMGalecto stock rallies 25% on positive data for myelofibrosis drugmsn.com - December 21 at 5:24 PMMAIA Biotechnology selects dose in Phase II NSCLC trialmsn.com - December 20 at 3:02 PMMAIA Biotechnology Announces Dose Selection in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancerfinance.yahoo.com - December 19 at 8:41 AMMAIA Biotechnology (MAIA) Price Target Increased by 10.89% to 14.28msn.com - December 16 at 10:04 AMBears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' Nowfinance.yahoo.com - December 1 at 1:21 PM‘The Artful Dodger’ Review: Hulu Gives Dickens a Twistmsn.com - November 28 at 8:07 PMMAIA Biotechnology Announces Closing of $4 Million Registered Direct Offeringfinance.yahoo.com - November 17 at 6:56 PMMAIA Biotechnology (NYSE: MAIA) Has Received FDA Orphan Drug Designation For THIO As A Treatment For Most Aggressive Brain Cancerbenzinga.com - November 16 at 9:05 AMWhy MAIA Biotechnology Stock Is Nosediving During Wednesday's Sessionmsn.com - November 15 at 2:10 PMMAIA Biotechnology Announces $4 Million Registered Direct Offeringfinance.yahoo.com - November 15 at 2:10 PMMAIA Biotechnology Gets FDA Orphan Designation for THIO in Glioblastomamarketwatch.com - November 10 at 12:13 PM Get MAIA Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for MAIA and its competitors with MarketBeat's FREE daily newsletter. Email Address FW: 234x Gain (Ad)This coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain. Click here. MAIA Media Mentions By Week MAIA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MAIA News Sentiment▼0.740.43▲Average Medical News Sentiment MAIA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MAIA Articles This Week▼51▲MAIA Articles Average Week Get MAIA Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for MAIA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: JAGX News ELDN News KZR News CELU News ANVS News CALC News IMMX News KRON News MURA News MNOV News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:MAIA) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MAIA Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
